Medical testing kit maker Omega Diagnostics (ODX:AIM) rises 3.2% to 19.7p as the company unveils a new mobile application (app) aimed at managing HIV.
The app works with Omega’s Visitect CD4 test, a mobile monitoring device that assesses the status of HIV suffers living in rural villages. The app allows test results to be automatically uploaded and sent direct to hospitals and other health organisations, potentially helping improve treatment programmes.
Based on Google's Android mobile operating system, launch is anticipated sometime during the next 12 months.
The mobile Visitect CD4 took the test into rural areas instead of relying on lab-based tools to assess patient need. This was the first step in adapting its technology to meet market need and the device is undergoing field tests in India and Kenya.
Omega is working with Groupe Speciale Mobile Association, an industry body for mobile operators aimed at developing mobile health programmes that are capable of connecting health and communication industries in sub-Sahara Africa. This could go a long to improving communication and information sharing between governments and aid agencies around the globe.
